Is Xvivo Perfusion AB publ stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
We cannot find any recorded dividends paid in our systems.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Xvivo Perfusion AB publ 10 years ago, but if you had invested on Friday 22nd of November 2019 when the price was $17.10, you would have made a profit of $24.13 per share or 141.11%
No, the average daily trading liquidity for Xvivo Perfusion AB publ is $115 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.
Xvivo Perfusion AB publ has no real debt, which is good in periods of high inflation. Xvivo Perfusion AB publ has a very good net profit margin of 27.21% and should have very high tolerances against inflation.
We have calculated the inflation risk for Xvivo Perfusion AB publ to be low [0.3 of 1]
US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.